Cardiol Therapeutics Inc.
NASDAQ:CRDL
Overview | Financials
Company Name | Cardiol Therapeutics Inc. |
Symbol | CRDL |
Currency | USD |
Price | 1.25 |
Market Cap | 102,004,250 |
Dividend Yield | 0% |
52-week-range | 0.96 - 3.12 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. David G. Elsley MBA |
Website | https://www.cardiolrx.com |
An error occurred while fetching data.
About Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD